Ambys Medicines
Ambys Medicines is a liver cell, gene, drug therapies founded in 2018.
1
Funding Rounds
$140.0m
Money raised
Funding series
Funding Series Analysis
The company Ambys Medicines has raised a total of $140m in funding over 1 rounds.
Key Insights:
- Ambys Medicines Series A round, August 2018: $140m
Ambys Medicines Series A round, August 2018
$140m
Industries
Ambys Medicines is active in the following industries: